4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …

Despite advancements in prevention and treatment, sudden cardiac death (SCD) remains a
leading cause of mortality and is responsible for approximately half of all deaths from …

Despite major advancements in cardiovascular medicine, sudden cardiac death (SCD)
continues to be an enormous medical and societal challenge, claiming millions of lives …

Atrial cardiomyopathy, characterized by abnormalities in atrial structure and function, is
associated with increased risk of adverse cardiovascular and neurocognitive outcomes …

Sudden cardiac death (SCD) is the most common and devastating outcome of sudden
cardiac arrest (SCA), defined as an abrupt and unexpected cessation of cardiovascular …

More than 40 years after the first implantable cardioverter-defibrillator (ICD) implantation,
sudden cardiac death (SCD) still accounts for more than five million deaths worldwide every …

Although overweight and obesity are established risk factors for some types of heart disease
including ischemic heart disease, heart failure and atrial fibrillation, less is known about the …

Sudden cardiac arrest (SCA) is one of the largest causes of mortality globally, with an out-of-
hospital survival below 10% despite intense research. This document outlines challenges in …

Genetic conditions, even those associated with identical gene mutations, can present with
variable clinical manifestations. One widely accepted explanation for this phenomenon is …

Rationale: Susceptibility to VT/VF (ventricular tachycardia/fibrillation) is difficult to predict in
patients with ischemic cardiomyopathy either by clinical tools or by attempting to translate …